chlorzoxazone has been researched along with MS (Multiple Sclerosis) in 2 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KLARE, V | 1 |
Reisner, H | 1 |
2 other studies available for chlorzoxazone and MS (Multiple Sclerosis)
Article | Year |
---|---|
[On the use of muscle relaxants, especially chlorzoxazone (Paraflex) in the field of rehabilitation programs].
Topics: Cardiovascular Agents; Chlorzoxazone; Disease; Extrapyramidal Tracts; Humans; Multiple Sclerosis; Mu | 1962 |
[Pharmacological treatment of pathological increases in muscle tonus].
Topics: Baclofen; Chlorzoxazone; Female; Humans; Multiple Sclerosis; Muscle Spasticity; Neural Pathways; Par | 1978 |